In the latest trading session,, 92.45 million Windtree Therapeutics Inc (NASDAQ:WINT) shares changed hands as the company’s beta touched 0.76. With the company’s most recent per share price at $0.85 changing hands around $0.29 or 53.10% at last look, the market valuation stands at $3.12M. WINT’s current price is a discount, trading about -86656.47% off its 52-week high of $737.43. The share price had its 52-week low at $0.52, which suggests the last value was 38.82% up since then. When we look at Windtree Therapeutics Inc’s average trading volume, we note the 10-day average is 0.4 million shares, with the 3-month average coming to 2.63 million.
Analysts gave the Windtree Therapeutics Inc (WINT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended WINT as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Windtree Therapeutics Inc’s EPS for the current quarter is expected to be 0.
Windtree Therapeutics Inc (NASDAQ:WINT) trade information
Instantly WINT is in green as seen in intraday trades today. With action 7.96%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -95.12%, with the 5-day performance at 7.96% in the green. However, in the 30-day time frame, Windtree Therapeutics Inc (NASDAQ:WINT) is 0.08% up. Looking at the short shares, we see there were 0.11 million shares sold at short interest cover period of 0.47 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 75.28%. The 2025 estimates are for Windtree Therapeutics Inc earnings to decrease by -366.22%.
WINT Dividends
Windtree Therapeutics Inc is expected to release its next quarterly earnings report on 2025-Apr-14.
Windtree Therapeutics Inc (NASDAQ:WINT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.01% of Windtree Therapeutics Inc shares while 1.39% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 1.39%.
Among Mutual Funds, the top two as of Mar 31, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . With 2.26 shares estimated at $1804.0 under it, the former controlled 0.06% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.01% of the shares, roughly 325.0 shares worth around $259.0.
